| Dr Deborah Dejager, PHARMD | |
|
166 Placerville Dr, Placerville, CA 95667-3919 | |
| (530) 622-6630 | |
| (530) 622-3071 |
| Full Name | Dr Deborah Dejager |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 166 Placerville Dr, Placerville, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326459165 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 58729 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Deborah Dejager, PHARMD 166 Placerville Dr, Placerville, CA 95667-3919 Ph: (530) 622-6630 | Dr Deborah Dejager, PHARMD 166 Placerville Dr, Placerville, CA 95667-3919 Ph: (530) 622-6630 |
News Archive
Researchers from the FAMU-FSU College of Engineering have developed a class of breakthrough motion sensors that could herald a near future of ubiquitous, fully integrated and affordable wearable technology.
MRI scans that detect shrinkage in specific regions of the mid-brain attacked by Alzheimer's disease accurately diagnose the neurodegenerative disease, even before symptoms interfere with daily function, a study by the Florida Alzheimer's Disease Research Center (ADRC) in Miami and Tampa found.
CytRx Corporation, a biopharmaceutical company specializing in oncology, announces that favorable clinical results from its Phase 1b/2 clinical trial with its tumor-targeting doxorubicin conjugate INNO-206 in patients with advanced solid tumors, primarily soft tissue sarcomas, are being presented today at the American Society of Clinical Oncology (ASCO) conference in Chicago.
In this Forbes opinion piece, John Lechleiter, president and chief executive officer of Eli Lilly and Company, examines the business of counterfeit medicines, writing, "With global sales last year estimated as high as $200 billion, counterfeit medicine is big business, and it's growing."
The National Osteoporosis Foundation today released a position statement providing evidence-based guidance and a national implementation strategy to help children and adolescents achieve optimal bone health, or what is known as "peak bone mass," early in life.
› Verified 6 days ago
Dr. David C Becker-ellison, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3964 Missouri Flat Rd, Placerville, CA 95667 Phone: 530-626-8642 | |
Amanuel Tesfamichael, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4300 Missouri Flat Rd, Placerville, CA 95667 Phone: 530-621-3447 | |
Dr. Zubair M Amin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 Marshall Way, Placerville, CA 95667 Phone: 530-662-2648 | |
Christie Hall, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1220 Broadway, Placerville, CA 95667 Phone: 530-626-5501 | |
Jackie Lyn David Velasco, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1220 Broadway, Placerville, CA 95667 Phone: 530-626-5501 Fax: 530-626-6147 | |
Peter Leslie Mcintyre, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3955 Missouri Flat Rd, Placerville, CA 95667 Phone: 530-295-2977 Fax: 530-295-2981 | |
Talvinder Bains, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4212 Missouri Flat Rd, Placerville, CA 95667 Phone: 530-748-2385 |